Overview

Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine whether early administration of Dexrazoxane prevents Doxorubicin induced cardiotoxicity.
Phase:
Phase 1
Details
Lead Sponsor:
Hui-Ming Chang
University of Arkansas
Treatments:
Dexrazoxane
Doxorubicin
Razoxane